International Assets Investment Management, LLC Igm Biosciences, Inc. Transaction History

International Assets Investment Management, LLC

$36.5 Billion
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2021 Jul 14, 2021	SELL	$57.98 - $96.6 $10,146 - $16,905	-175 Closed	0 $0
Q4 2020 Jan 22, 2021	BUY	$47.41 - $115.03 $8,296 - $20,130	175 New	175 $15.5 Million

Others Institutions Holding IGMS

# of Institutions

Shares Held

21.4M

Call Options Held

39.5K

Put Options Held

16.5K

Baker Bros. Advisors LP New York, NY

4.09M
Shares

$70.6 Million
0.37% of portfolio
Price T Rowe Associates Inc Baltimore, MD

4.08M
Shares

$70.3 Million
0.0% of portfolio
Artal Group S.A. Luxembourg, N4

3.33M
Shares

$57.5 Million
1.45% of portfolio
Redmile Group, LLC San Francisco, CA

3.07M
Shares

$53 Million
1.38% of portfolio
Goldman Sachs Group Inc New York, NY

1.33M
Shares

$23 Million
0.0% of portfolio

View Full List

About IGM Biosciences, Inc.

Ticker IGMS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,969,000
Market Cap $500M
Description
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...

More about IGMS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of International Assets Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on International Assets Investment Management, LLC with notifications on news.

Account